Results 71 to 80 of about 451,786 (281)

Isthmus Dependent Atrial Flutter Cycle Length Correlates with Right Atrial Cross-Sectional Area

open access: yesIndian Pacing and Electrophysiology Journal, 2009
Background: Right atrial flutter cycle length can prolong in the presence of antiarrhythmic drug therapy. We hypothesized that the cycle length of right atrial isthmus dependent flutter would correlate with right atrial cross-sectional area measurements.
Kousik Krishnan   +6 more
doaj  

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke [PDF]

open access: yes, 2016
BACKGROUND Previous studies conducted between 1997 and 2003 estimated that the risk of stroke or an acute coronary syndrome was 12 to 20% during the first 3 months after a transient ischemic attack (TIA) or minor stroke.
Albers, Gregory W.   +20 more
core   +2 more sources

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen   +4 more
wiley   +1 more source

Electrophysiological Mechanisms of Atrial Flutter

open access: yesIndian Pacing and Electrophysiology Journal, 2006
Atrial flutter (AFL) is a common arrhythmia in clinical practice. Several experimental models such as tricuspid regurgitation model, tricuspid ring model, sterile pericarditis model and atrial crush injury model have provided important information about
Ching- Tai Tai, Shin-Ann Chen
doaj  

Atrial Tachyarrhythmias and Atrial Flutter: the Basics of Diagnostics and Modern Opportunities of Therapy

open access: yesРациональная фармакотерапия в кардиологии, 2019
The article is devoted to the description of all types of atrial tachyarrhythmias, including inappropriate sinus tachycardia, which, as a rule, is not paid enough attention in the domestic literature, sinoatrial node reentrant tachycardia, focal and ...
Yu. A. Bunin   +3 more
doaj   +1 more source

Atrial standstill in a horse with cardiac glycoside intoxication [PDF]

open access: yes, 2012
C
De Clercq, Dominique   +4 more
core   +1 more source

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Guidelines recommend a trial of one or more antiarrhythmic drugs before catheter ablation is considered in patients with atrial fibrillation. However, first-line ablation may be more effective in maintaining sinus rhythm. METHODS We randomly
J. Andrade   +20 more
semanticscholar   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Management of paroxysmal atrial flutter that occurred in an outpatient prior to dental surgery: a case report

open access: yesBMC Oral Health, 2019
Background It is essential to accomplish the appropriate emergency care particularly in patients undergoing stressful dento-oral surgical procedures.
Hajime Shimoda, Tetsu Takahashi
doaj   +1 more source

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy